The partnership between Emergent BioSolutions and Rocketvax drives innovation in global health, focusing on vaccine development for infectious diseases, cancer, and autoimmune disorders. Rocketvax's live-attenuated nasal spray SARS-CoV-2 vaccine exhibits…
Asia's financial landscape presents both challenges and opportunities amid global economic uncertainties. Penny stocks offer high risk and high reward, acting as potential wildcards for investors. Yangzijiang Shipbuilding (Holdings) shows…
Flagship Pioneering unveils Lila Sciences, a biotech company focused on autonomous AI-driven laboratories with $200 million in seed funding. Aiming to transform scientific research, Lila's AI platform autonomously designs and…
Immunai integrates AI with immunology to transform medical innovation. Mikael Dolsten, former Pfizer CSO, joins Immunai's Board, bringing expertise in drug development and past successes like the mRNA COVID-19 vaccine.…
Oncolytics Biotech Inc. faces financial challenges, reporting a Q4 2024 net loss of $8 million and declining cash reserves. The company’s flagship oncolytic virus, pelareorep, shows promise in cancer therapeutics,…
Tevogen Bio leverages AI to revolutionize precision medicine, merging proprietary datasets with generative AI models. The company's approach focuses on transforming therapeutic applications from generalized to highly personalized treatments. AI's…
Automation, powered by advanced AI, is transforming laboratories, enhancing precision and efficiency. Robotic systems boost throughput, reliability, and scalability, crucial for fields like drug discovery and genomics. AI-driven algorithms help…
Marker Therapeutics is highly rated by Canaccord Genuity for its innovative cancer cell therapies, aiming for an target price from . Krystal Biotech garners a strong buy from Jefferies, targeting…
Colossal Biosciences aims to resurrect the woolly mammoth, extinct for millennia, potentially being the first de-extinct species brought back by 2028. The "woolly mouse," engineered with mammoth genes, exhibits traits…
Krystal Biotech is experiencing a significant rise in short interest, with 14.58% of its shares sold short. This increase signifies a shift in investor sentiment, implying expectations of a short-term…